Medpace Holdings paid its 5 named executives $20.2M in total in FY2025 (Dec). CEO August J. Troendle was paid $11.4M of that.
Pay$100 in the stock at the end of FY20 → $403
Pay of each named executive
August J. TroendleChief Executive Officer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Susan E. BurwigExecutive Vice President, Operations
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
Jesse J. GeigerPresident
| FY2025 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Stephen P. EwaldGeneral Counsel and Corporate Secretary
| FY2025 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
4 years
Kevin M. BradyChief Financial Officer and Treasurer
| FY2025 (Dec) | |||||||
| FY2024 (Dec) | |||||||
| FY2023 (Dec) | Not disclosed | ||||||
| FY2022 (Dec) | Not disclosed | ||||||
| FY2021 (Dec) | Not disclosed |
5 years
CEO pay against the pay peers
In FY2024 (Dec), the median CEO pay of the 4 peers with pay on file was $15.6M. The CEO of Medpace Holdings was paid $8.6M, 45% below the median.
- 1Iqvia Holdings
- 2Labcorp Holdings
- 3Revvity
- 4Medpace HoldingsThis company
- 5Bruker
- 6Agilent TechnologiesNot disclosed
- 7BIO-TECHNENot disclosed
- 8Catalent, Inc.Not disclosed
- 9Charles River LaboratoriesNot disclosed
- 10Fortrea Holdings Inc.Not disclosed
- 11ICON plcNot disclosed
- 12Quest DiagnosticsNot disclosed
- 13Sotera Health CompanyNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.